Global M&A activity remains elevated heading into late 2026, with deal value rising 38% year-over-year through the first nine months amid a record 34 megadeals that accounted for nearly half of total volume. AI infrastructure needs, including power and data centers, alongside technology and pharmaceutical consolidation, continue to drive strategic buyers, while private equity maintains selective participation despite softer exits. Recent Q3 softening tied to higher yields has tempered momentum, yet cross-border flows and corporate balance sheets support further transactions through 2027. Key catalysts include upcoming earnings, regulatory reviews, and any shifts in Treasury yields or Fed policy that could influence financing costs and valuations. Trader consensus reflects these structural tailwinds alongside execution risks in a selective market.